Catheter ablation vs antiarrhythmic drug therapy for first-line treatment of atrial fibrillation in United States clinical practice.
| Publicado en: | Heart Rhythm Vol. 23; no. 8; pp. 1705 - 1717 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Elsevier B.V.
Aug2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195628268&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 195628268 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15475271 EHI jtl: Heart Rhythm issn: 15475271 maglogo: N pubinfo: dt: Aug2026 vid: 23 iid: 8 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 195628268 10.1016/j.hrthm.2025.07.061 195628268 ppf: 1705 ppct: 12 formats: tig: atl: Catheter ablation vs antiarrhythmic drug therapy for first-line treatment of atrial fibrillation in United States clinical practice. aug: au: Pimentel, Rhea C. Khanna, Rahul Maccioni, Sonia Zhang, Dongyu Piccini, Jonathan P. affil: Department of Cardiovascular Medicine, The University of Kansas Health System, Kansas City, Kansas sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|